PL260922A1 - Method of obtaining novel optically active substituted 1,4-dihydropyridines - Google Patents

Method of obtaining novel optically active substituted 1,4-dihydropyridines

Info

Publication number
PL260922A1
PL260922A1 PL1985260922A PL26092285A PL260922A1 PL 260922 A1 PL260922 A1 PL 260922A1 PL 1985260922 A PL1985260922 A PL 1985260922A PL 26092285 A PL26092285 A PL 26092285A PL 260922 A1 PL260922 A1 PL 260922A1
Authority
PL
Poland
Prior art keywords
dihydropyridines
optically active
novel optically
active substituted
obtaining novel
Prior art date
Application number
PL1985260922A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL260922A1 publication Critical patent/PL260922A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL1985260922A 1984-08-24 1985-08-22 Method of obtaining novel optically active substituted 1,4-dihydropyridines PL260922A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843431152 DE3431152A1 (de) 1984-08-24 1984-08-24 Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
PL260922A1 true PL260922A1 (en) 1987-02-09

Family

ID=6243791

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1985260922A PL260922A1 (en) 1984-08-24 1985-08-22 Method of obtaining novel optically active substituted 1,4-dihydropyridines
PL25509085A PL255090A1 (en) 1984-08-24 1985-08-22 Method of obtaining novel optically active substituted 1,4-dihydropyridines

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL25509085A PL255090A1 (en) 1984-08-24 1985-08-22 Method of obtaining novel optically active substituted 1,4-dihydropyridines

Country Status (14)

Country Link
US (1) US4760147A (US20100223739A1-20100909-C00005.png)
EP (1) EP0172509A3 (US20100223739A1-20100909-C00005.png)
JP (1) JPS6165883A (US20100223739A1-20100909-C00005.png)
KR (1) KR870002135A (US20100223739A1-20100909-C00005.png)
AU (1) AU4660685A (US20100223739A1-20100909-C00005.png)
CA (1) CA1257255A (US20100223739A1-20100909-C00005.png)
DE (1) DE3431152A1 (US20100223739A1-20100909-C00005.png)
DK (1) DK384785A (US20100223739A1-20100909-C00005.png)
ES (1) ES8609314A1 (US20100223739A1-20100909-C00005.png)
FI (1) FI853164L (US20100223739A1-20100909-C00005.png)
GR (1) GR852034B (US20100223739A1-20100909-C00005.png)
HU (1) HU197325B (US20100223739A1-20100909-C00005.png)
PL (2) PL260922A1 (US20100223739A1-20100909-C00005.png)
ZA (1) ZA856402B (US20100223739A1-20100909-C00005.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6191185A (ja) * 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−1,4−ジヒドロピリジン誘導体
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
US4988384A (en) * 1987-02-09 1991-01-29 Monsanto Company Penta-substituted pyridine compounds, herbicidal compositions and herbicidal method of use
DE3883627D1 (de) * 1987-03-27 1993-10-07 Byk Gulden Lomberg Chem Fab 1,4-Dihydropyridin-Enantiomere.
EP1662868A4 (en) * 2003-08-29 2010-10-20 Luzenac America Inc COMPOSITION AND METHOD FOR HARVEST PROTECTION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1200928B (it) * 1983-07-11 1989-01-27 Malesci Sas Procedimento per la preparazione di 1-piridil-alchil-4-aril piperazine utili per la loro attivita' antiipertensiva,lloro separazione nei relativi antipodi ottici e composti stereoisomeri cosi' ottenuti

Also Published As

Publication number Publication date
DK384785A (da) 1986-02-25
AU4660685A (en) 1986-03-20
ES8609314A1 (es) 1986-07-16
EP0172509A3 (de) 1988-01-07
DE3431152A1 (de) 1986-03-06
ES546387A0 (es) 1986-07-16
FI853164A0 (fi) 1985-08-16
HUT40648A (en) 1987-01-28
DK384785D0 (da) 1985-08-23
JPS6165883A (ja) 1986-04-04
ZA856402B (en) 1986-04-30
US4760147A (en) 1988-07-26
FI853164L (fi) 1986-02-25
KR870002135A (ko) 1987-03-30
PL255090A1 (en) 1986-12-30
EP0172509A2 (de) 1986-02-26
HU197325B (en) 1989-03-28
GR852034B (US20100223739A1-20100909-C00005.png) 1985-12-18
CA1257255A (en) 1989-07-11

Similar Documents

Publication Publication Date Title
PL256983A1 (en) Method of obtaining novel derivatives of cyclohexanodione-1,3
PL256985A1 (en) Method of obtaining novel derivatives of cyclohexanodione-1,3
PL256260A1 (en) Method of obtaining novel alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolincarboxylic acids
PL271722A1 (en) Method of obtaining novel 2',3'-didesoxynucleosides
PL256984A1 (en) Method of obtaining novel derivatives of cyclohexanodione-1,3
PL252773A1 (en) Method of obtaining novel derivatives of 1,4-dihydropyridine
BG43865A3 (en) Method for preparing of 1, 3- disubstituted 2- oxyindols
PL268618A1 (en) The method of manufacture of 1,4-dihydropyridine derivatives
PL253821A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
PL255940A1 (en) Method of obtaining novel 1,2,4-triazolocarbaminates
PL253820A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
PL251584A1 (en) Method of obtaining novel derivatives of 1,4-dihydropyridine
DK436685A (da) Fremgangsmaade til fremstilling af 2,4-dichlor-5-fluor-benzoesyre
PL255090A1 (en) Method of obtaining novel optically active substituted 1,4-dihydropyridines
DK687188D0 (da) Fremgangsmaade til fremstilling af 2,2'-oxodisuccinat
DK162997C (da) Fremgangsmaade til fremstilling af 5,6,7,8-tetrahydrofolinsyre
PL272668A1 (en) Method of obtaining 4,4'-dinitroethylbenedisulfonic-2,2'acid
GB2163050B (en) Method of treating or preventing diseases using 1,4-dihydropyridines
PL255399A1 (en) Method of obtaining 1,3-diacyl-2-ketoindoles
PL255441A1 (en) Method of obtaining novel substituted 4,5-dihydro-/2h/-pyridazinones-3
PL256694A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
PL256717A1 (en) Method of obtaining novel 1,4-dihydropyridinolactafungicidal specific nes
SU1155596A1 (en) Method of obtaining 1,4-dinitroimidazoles
SU1150248A1 (en) Method of obtaining 2,4-diaminomesitylene-6-sulfoacid
PL257530A1 (en) Method of obtaining novel derivatives of 1,4-dihydropyridine